Cardiovascular Adverse Events and Mitigation Strategies for Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy | Zendy

AI Assistant Blog Pricing

Open Access

Cardiovascular Adverse Events and Mitigation Strategies for Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy

Author(s) -

Lisa Nodzon,

Anecita Fadol,

Sara Tinsley

Publication year - 2022

Publication title -

journal of the advanced practitioner in oncology

Language(s) - English

Resource type - Journals

eISSN - 2150-0886

pISSN - 2150-0878

DOI - 10.6004/jadpro.2022.13.2.4

Subject(s) - medicine , myeloid leukemia , cardiotoxicity , intensive care medicine , tyrosine kinase inhibitor , adverse effect , oncology , chronic myelogenous leukemia , cancer , leukemia , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.